MMJ PhytoTech Ltd (ASX:MMJ) 31 August 2018 Investor Presentation
MMJ PhytoTech Ltd (ASX:MMJ) (OTCMKTS:MMJJF) provides the Company's latest Investor Presentation.
MMJ PhytoTech Ltd (ASX:MMJ) (OTCMKTS:MMJJF) provides the Company's latest Investor Presentation.
Your directors present their report, together with the financial statements, on the consolidated entity consisting of The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF) and the entities it controlled at the end of, or during, the half-year ended 30 June 2018.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to confirm the lodgement of the MMJ Appendix 4E for the financial year ended 30 June 2018.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a copy of an investor presentation recently issued by Harvest One Cannabis Inc. (CVE:HVT).
The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to present a set of proposed resolutions and explanatory statements, which will see the merger of Medical Cannabis Limited into the Company and the acquisition of MedCan Australia, enabling the Company to have all the licences and facilities currently needed, to progress the Cannabis business and humanitarian goals of the company.
The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to advise that it has entered into a Heads of Agreement with Sebastian and Samuel Edwards to acquire their Health Food Brands.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to note the attached news release by MediPharm Labs Inc confirming the appointment of two key marketing and business development senior management executives.